A. Zaheer, S.P. Raman, M.L. Rosado-de-Christenson, S. Martínez-Jiménez, S.H. Garrana, G. Fananapazir, D. Rogers, B.R. Foster: Imaging Anatomy: Chest, Abdomen, Pelvis, 3rd Edition Luigi Mansi Book Review 10 January 2024 Pages: 1201 - 1202
After one year of ChatGPT’s launch: reflections on artificial intelligence in scientific writing Yuan FengJinquan HanXiaoli Lan Editorial 18 January 2024 Pages: 1203 - 1204
Advances in targeted alpha therapy of cancer Mike SathekgeAlfred Morgenstern Editorial 20 February 2024 Pages: 1205 - 1206
Alpha emitter isotopes and PSMA ligands: the near future therapeutic prospective for castration-resistant prostate cancer Fabio VolpeLeandra PiscopoMichele Klain Editorial 23 December 2023 Pages: 1207 - 1209
Beyond stillness: the importance of tackling patient’s motion for reliable parametric imaging Alessia ArtesaniLaura ProvidênciaCharalampos Tsoumpas Editorial 13 January 2024 Pages: 1210 - 1212
Letter to the Editor: FDG Liver Biodistribution Dale L. BaileyGeoffrey P. SchembriPaul J. Roach Letter to the Editor 23 February 2024 Pages: 1213 - 1214
Ultra-fast whole-body bone tomoscintigraphies achieved with a high-sensitivity 360° CZT camera and a dedicated deep-learning noise reduction algorithm Achraf BahloulAntoine VergerLaetitia Imbert Short Communication 12 December 2023 Pages: 1215 - 1220
[177Lu]Lu-labeled anti-claudin-18.2 antibody demonstrated radioimmunotherapy potential in gastric cancer mouse xenograft models Ziqing ZengLiqiang LiHua Zhu Original Article 08 December 2023 Pages: 1221 - 1232
Adhesion molecule–targeted magnetic particle imaging nanoprobe for visualization of inflammation in acute lung injury Pengli GaoYu LiuJie Tian Original Article 14 December 2023 Pages: 1233 - 1245
Theranostic role of 89Zr- and 177Lu-labeled aflibercept in breast cancer Qi YangZhao ChenLei Kang Original Article 23 December 2023 Pages: 1246 - 1260
Detection of metabolic adaptation in a triple-negative breast cancer animal model with [18F]choline-PET imaging as a surrogate for drug resistance Andres A. KohanMathieu LupienPatrick Veit-Haibach Short Communication 14 December 2023 Pages: 1261 - 1267
EANM guidance document: dosimetry for first-in-human studies and early phase clinical trials Caroline StokkeSilvano GnesinJonathan Gear Guidelines Open access 17 February 2024 Pages: 1268 - 1286
FDG-PET/CT for investigation of pyrexia of unknown origin: a cost of illness analysis Bonnia LiuRonald MaAndrew M. Scott Original Article 07 December 2023 Pages: 1287 - 1296
[18F]FDG PET/CT for therapeutic assessment of Abatacept in early-onset polymyalgia rheumatica Bastien AllardValérie Devauchelle-PensecSolène Querellou Original Article 14 December 2023 Pages: 1297 - 1309
High-temporal resolution functional PET/MRI reveals coupling between human metabolic and hemodynamic brain response Andreas HahnMurray B. ReedRupert Lanzenberger Original Article Open access 06 December 2023 Pages: 1310 - 1322
Effects of medication on dopamine transporter imaging using [123I]I-FP-CIT SPECT in routine practice Yuliya PiatkovaMatthieu DoyenAntoine Verger Original Article 20 December 2023 Pages: 1323 - 1332
Automated identification of uncertain cases in deep learning-based classification of dopamine transporter SPECT to improve clinical utility and acceptance Thomas BudenkotteIvayla ApostolovaRalph Buchert Original Article Open access 22 December 2023 Pages: 1333 - 1344
Expanding the clinical indications of [18F]fluorocholine PET/CT in primary hyperparathyroidism: the evidence cannot be evaded Giorgio TregliaAlessio RizzoArnoldo Piccardo Editorial 23 December 2023 Pages: 1345 - 1348
Performance of [18F]fluorocholine PET/CT in MEN1-related primary hyperparathyroidism before initial surgery or for persistent/recurrent disease Aymeric BoucherJulia DelabieDavid Taïeb Original Article 07 December 2023 Pages: 1349 - 1360
Multicenter development of a PET-based risk assessment tool for product-specific outcome prediction in large B-cell lymphoma patients undergoing CAR T-cell therapy Conrad-Amadeus VoltinAndrea PaccagnellaChristine Hanoun Original Article Open access 20 December 2023 Pages: 1361 - 1370
Dynamic total-body PET/CT imaging with reduced acquisition time shows acceptable performance in quantification of [18F]FDG tumor kinetic metrics Guobing LiuYimeng ShiHongcheng Shi Original Article 11 December 2023 Pages: 1371 - 1382
CXCR4-directed PET/CT with [68 Ga]Ga-pentixafor in solid tumors—a comprehensive analysis of imaging findings and comparison with histopathology Niklas DreherStefanie HahnerRudolf A. Werner Original Article Open access 12 December 2023 Pages: 1383 - 1394
Pre-clinical evaluation of biomarkers for the early detection of nephrotoxicity following alpha-particle radioligand therapy Mengshi LiClaudia Robles-PlanellsDiana Zepeda-Orozco Original Article Open access 14 December 2023 Pages: 1395 - 1408
Therapeutic efficacy of an alpha-particle emitter labeled anti-GD2 humanized antibody against osteosarcoma—a proof of concept study Ioanna LiatsouYingli FuGeorge Sgouros Original Article 18 December 2023 Pages: 1409 - 1420
Molecular imaging of IDH-mutant gliomas in the new era of IDH inhibitors: preparing for future challenges Gaia NinattiRosa Maria MorescoMartina Sollini Editorial 09 January 2024 Pages: 1421 - 1422
Development and validation of clinical-radiomics analysis for preoperative prediction of IDH mutation status and WHO grade in diffuse gliomas: a consecutive l-[methyl-11C] methionine cohort study with two PET scanners Weiyan ZhouJianbo WenTao Hua Original Article 19 December 2023 Pages: 1423 - 1435
The clinical acceptability of short versus long duration acquisitions for head and neck cancer using long-axial field-of-view PET/CT: a retrospective evaluation Riccardo MeiThomas PykaIan Alberts Original Article Open access 14 December 2023 Pages: 1436 - 1443
Comparative assessment of radiation therapy–induced vasculitis using [18F]FDG-PET/CT in patients with non-small cell lung cancer treated with proton versus photon radiotherapy D. EvansonM. GriffinA. Alavi Original Article Open access 14 December 2023 Pages: 1444 - 1450
Prediction of therapy response of breast cancer patients with machine learning based on clinical data and imaging data derived from breast [18F]FDG-PET/MRI Kai JannuschFrederic DietzelJulian Caspers Original Article Open access 22 December 2023 Pages: 1451 - 1461
The EANM Focus 5 consensus on ‘molecular imaging and theranostics in prostate cancer’: the future begins today Daniela-Elena Oprea-LagerSteven MacLennanStefano Fanti Editorial 27 January 2024 Pages: 1462 - 1463
Incorporating the [68Ga]Ga-PSMA PET/CT PRIMARY score into the selection criteria for prostate cancer patients eligible for active surveillance Levent KabasakalRuştu TurkayBulent Onal Editorial 12 February 2024 Pages: 1464 - 1466
Prediction of clinically significant prostate cancer by [68 Ga]Ga-PSMA-11 PET/CT: a potential tool for selecting patients for active surveillance Kaan AkcayAli KibarLevent Kabasakal Original Article 19 December 2023 Pages: 1467 - 1475
A convolutional neural network–based system for fully automatic segmentation of whole-body [68Ga]Ga-PSMA PET images in prostate cancer Esmail JafariAmin ZareiMajid Assadi Original Article 14 December 2023 Pages: 1476 - 1487
Intense PSMA expression of the uvula detected by [68 Ga]Ga-PSMA-PET/CT Lisa GlantschnigAlexander DierksMalte Kircher Image of the Month Open access 13 November 2023 Pages: 1488 - 1489
First-in-human SPECT/CT imaging of [212Pb]Pb-VMT-α-NET in a patient with metastatic neuroendocrine tumor Enrico MichlerDavid KästnerJörg Kotzerke Image of the Month Open access 22 November 2023 Pages: 1490 - 1492
Impact of patient motion on parametric PET imaging Alessia ArtesaniJoyce van SluisCharalampos Tsoumpas Image of the Month Open access 15 January 2024 Pages: 1493 - 1494
Correction to: Theranostic role of 89Zr‑ and 177Lu‑labeled aflibercept in breast cancer Qi YangZhao ChenLei Kang Correction 12 January 2024 Pages: 1495 - 1495